Tidal Vision Acquires ViaeX Technologies Inc.

Tidal Vision Products Acquires Clear Water Services

August 8, 2023

Environmental Services

Tidal Vision Products, Inc. has acquired long-time customer Clear Water Services to integrate Clear Water's mobile and modular water treatment systems with Tidal Vision's chitosan-based Tidal Clear technologies. The acquisition gives Tidal Vision expanded deployment capabilities, access to field performance data across 200+ sites to accelerate R&D, and strengthens Clear Water Services' capacity to build advanced treatment systems and expand its national footprint.

Cambridge Companies SPG Leads $140M Series B in Tidal Vision

February 5, 2025

Biotechnology

Tidal Vision raised an oversubscribed $140 million Series B led by Cambridge Companies SPG with participation from Eni Next, Milliken & Company, KIRKBI Climate, Convent Capital, SWEN Capital Partners' Blue Ocean Fund, MBX Capital, IDO Investments (Oman Investment Authority) and others. The growth equity will fund expanded commercial-scale production, new facilities in Europe and the U.S. (Texas and Ohio), and accelerated R&D to scale chitosan-based biomolecular solutions for water treatment, agriculture, and materials markets globally.

Eliassen Group Acquires VIA Technical

October 14, 2024

Staffing & HR

Eliassen Group, a strategic consulting and talent solutions firm based in Reading, Massachusetts, has acquired VIA Technical, an IT talent services firm serving the San Diego market. The acquisition expands Eliassen's Southern California footprint and broadens its access to mid-to-senior technical talent and services across areas like applications, network/systems infrastructure, and end-user support.

Vertex Pharmaceuticals Acquires ViaCyte for $320M

July 11, 2022

Biotechnology

Vertex Pharmaceuticals agreed to acquire clinical-stage cell therapy company ViaCyte for $320 million in cash. The deal gives Vertex additional stem cell lines, IP and GMP manufacturing capabilities intended to accelerate its VX-880 and other cell replacement therapy programs for type 1 diabetes.

Blue Water Ventures International Acquires Psycheceutical, Inc.

January 20, 2022

Biotechnology

Blue Water Ventures International, Inc. (BWVI) has completed a merger to acquire Psycheceutical, Inc., making the biotech a wholly-owned subsidiary. BWVI — a publicly-listed company — will pivot its business to focus on psychedelic drug development and intends to provide near-term capital as Psycheceutical advances its delivery technologies toward initial clinical trials.

Motion Dynamics Acquires ViaMed Holdings

December 3, 2020

Medical Devices

Motion Dynamics LLC, a portfolio company of Vance Street Capital, has acquired ViaMed Holdings LLC in the platform’s first strategic add‑on acquisition. The deal expands Motion Dynamics’ micro‑precision manufacturing capabilities (coiling, braiding, nitinol shape‑setting) for medical device OEMs and contract manufacturers; terms were not disclosed.